121 related articles for article (PubMed ID: 7075109)
1. Acyclovir kinetics in end-stage renal disease.
Laskin OL; Longstreth JA; Whelton A; Rocco L; Lietman PS; Krasny HC; Keeney RE
Clin Pharmacol Ther; 1982 May; 31(5):594-601. PubMed ID: 7075109
[TBL] [Abstract][Full Text] [Related]
2. Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure.
Krasny HC; Liao SH; de Miranda P; Laskin OL; Whelton A; Lietman PS
Am J Med; 1982 Jul; 73(1A):202-4. PubMed ID: 7102703
[TBL] [Abstract][Full Text] [Related]
3. Disposition of intravenous radioactive acyclovir.
de Miranda P; Good SS; Laskin OL; Krasny HC; Connor JD; Lietman PS
Clin Pharmacol Ther; 1981 Nov; 30(5):662-72. PubMed ID: 7297024
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans.
Laskin OL; Longstreth JA; Saral R; de Miranda P; Keeney R; Lietman PS
Antimicrob Agents Chemother; 1982 Mar; 21(3):393-8. PubMed ID: 7103443
[TBL] [Abstract][Full Text] [Related]
5. Effect of renal failure on the pharmacokinetics of acyclovir.
Laskin OL; Longstreth JA; Whelton A; Krasny HC; Keeney RE; Rocco L; Lietman PS
Am J Med; 1982 Jul; 73(1A):197-201. PubMed ID: 7102702
[No Abstract] [Full Text] [Related]
6. High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study.
Helldén A; Odar-Cederlöf I; Diener P; Barkholt L; Medin C; Svensson JO; Säwe J; Ståhle L
Nephrol Dial Transplant; 2003 Jun; 18(6):1135-41. PubMed ID: 12748346
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fate of radioactive acyclovir in humans.
de Miranda P; Good SS; Krasny HC; Connor JD; Laskin OL; Lietman PS
Am J Med; 1982 Jul; 73(1A):215-20. PubMed ID: 7102704
[TBL] [Abstract][Full Text] [Related]
8. Acyclovir kinetics after intravenous infusion.
de Miranda P; Whitley RJ; Blum MR; Keeney RE; Barton N; Cocchetto DM; Good S; Hemstreet GP; Kirk LE; Page DA; Elion GB
Clin Pharmacol Ther; 1979 Dec; 26(6):718-28. PubMed ID: 227639
[TBL] [Abstract][Full Text] [Related]
9. Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans.
Laskin OL; de Miranda P; King DH; Page DA; Longstreth JA; Rocco L; Lietman PS
Antimicrob Agents Chemother; 1982 May; 21(5):804-7. PubMed ID: 7103460
[TBL] [Abstract][Full Text] [Related]
10. Single-dose pharmacokinetics of acyclovir.
Spector SA; Connor JD; Hintz M; Quinn RP; Blum MR; Keeney RE
Antimicrob Agents Chemother; 1981 Apr; 19(4):608-12. PubMed ID: 7247383
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.
Whitley RJ; Blum MR; Barton N; de Miranda P
Am J Med; 1982 Jul; 73(1A):165-71. PubMed ID: 7102700
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir clinical pharmacology. An overview.
Lietman PS
Am J Med; 1982 Jul; 73(1A):193-6. PubMed ID: 7048912
[TBL] [Abstract][Full Text] [Related]
13. Influence of ALDH2 genetic polymorphisms on aciclovir pharmacokinetics following oral administration of valaciclovir in Japanese end-stage renal disease patients.
Hara K; Suyama K; Itoh H; Nagashima S
Drug Metab Pharmacokinet; 2008; 23(5):306-12. PubMed ID: 18974607
[TBL] [Abstract][Full Text] [Related]
14. [Acyclovir encephalopathy in a peritoneal dialysis patient despite adjusting the dose of oral acyclovir: a case report].
Kawabe Matsukawa M; Suzuki Y; Ikuma D; Suwabe T; Uesaka Y; Sugimoto I
Rinsho Shinkeigaku; 2019 Dec; 59(12):834-839. PubMed ID: 31761838
[TBL] [Abstract][Full Text] [Related]
15. Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient.
Yang HH; Hsiao YP; Shih HC; Yang JH
Int J Dermatol; 2007 Aug; 46(8):883-4. PubMed ID: 17651180
[TBL] [Abstract][Full Text] [Related]
16. Overview of acyclovir pharmacokinetic disposition in adults and children.
Blum MR; Liao SH; de Miranda P
Am J Med; 1982 Jul; 73(1A):186-92. PubMed ID: 7048911
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney injury and acyclovir-associated encephalopathy after administration of valacyclovir in an elderly person with normal renal function: A case report and literature review.
Kenzaka T; Sugimoto K; Goda K; Akita H
Medicine (Baltimore); 2021 May; 100(21):e26147. PubMed ID: 34032768
[TBL] [Abstract][Full Text] [Related]
18. Sotalol kinetics in renal insufficiency.
Blair AD; Burgess ED; Maxwell BM; Cutler RE
Clin Pharmacol Ther; 1981 Apr; 29(4):457-63. PubMed ID: 7471612
[TBL] [Abstract][Full Text] [Related]
19. Acyclovir concentrations and tolerance during repetitive administration for 18 days.
Laskin OL; Saral R; Burns WH; Angelopulos CM; Lietman PS
Am J Med; 1982 Jul; 73(1A):221-4. PubMed ID: 7048913
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of oral acyclovir in patients on continuous ambulatory peritoneal dialysis.
Stathoulopoulou F; Almond MK; Dhillon S; Raftery MJ
Nephron; 1996; 74(2):337-41. PubMed ID: 8893152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
